UC San Francisco Electronic Theses and Dissertations

Total Page:16

File Type:pdf, Size:1020Kb

UC San Francisco Electronic Theses and Dissertations UCSF UC San Francisco Electronic Theses and Dissertations Title Immune regulation by the endocannabinoid N-arachidonoyl dopamine (NADA) Permalink https://escholarship.org/uc/item/7wj3d52v Author Lawton, Samira Khakpour Publication Date 2017 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California Immune regulation by the endocannabinoid rV-ar: dopamine by DISSERTATION Submitted in partial satisfaction of the requirements for the degree of Copyright 2017 by Samira Khakpour Lawton ii To Kipp Lawton, my best friend iii ACKNOWLEDGEMENTS First, I would like to thank my graduate advisor, Judith Hellman, for her unconditional support and scientific guidance. Through creativity and determination, we set forth into new frontiers, and I am a better scientist for it. She taught me to follow my heart and never fear the unknown. Judith allowed me to be independent while never feeling alone. I am deeply grateful to have had the chance to experience graduate school with her by my side and will miss her immensely. I also truly appreciate having been able to do science with the rest of the Hellman lab. Fengyun Xu and Erika Wong spent uncountable hours repeating complex experiments, and Alphonso Tran sacrificed endless nights and weekends to help move this project along. I sincerely could not have done this without all of their help and support. Finally, I greatly appreciate my undergraduate research advisor, Will DePaolo, who gave me the foundation in research that has been crucial to my success at UCSF. I would also like to thank my thesis committee, Matt Springer, Shaun Coughlin, and Mehrdad Matloubian, for their consistent guidance and inspiration. Their perspectives have been critical for helping this project transform from an idea into impactful science. Thank you to everyone in the Biomedical Sciences program, especially Lisa Magargal, Demian Sainz, and my academic advisor, Mark Ansel. They have always been there for me with open arms when I needed them, and even when I did not. They made the decision to come to UCSF such an easy one, and I thank them for everything that they have done for me. iv I would like to thank my classmates and friends who have been my family throughout these five years. You have made moving across the country such a seamless transition, and have been there through all of the good and bad. Thank you Brittany Gianetti, Arshiya Fazal, Olga Karagoz, Anju Goyal, Jeewon Lee, Sarah Moshary, and so many others. Thank you Juliet Goldsmith, who never failed to show up on my doorstep with food and wine, thus creating unrealistic expectations for all future friendships. Thank you to my family for their unbelievable love and support through all these years, especially my parents, Bagher and Soraya. They have always encouraged my curiosity and pretended to understand what I was talking about. I am who I am because of them. Thank you to my in-laws, Cathy and Patrick, who opened up their hearts to me when I was only twelve years old and have been family ever since. They have done everything in their power to help and support me, even when I hauled their youngest son 2000 miles away. Thank you to my now official siblings, Erin and Brendan. Not everyone is quite as lucky to inherit such a loving and fun family. And finally, I would like to thank Kipp Lawton, for putting up with me and believing in me through all of this. It is so difficult to find the right way to thank someone who has given me unrelenting and unconditional support for over twelve years. None of this would have been possible without him. While research could be lonely, he showed me that home never had to be. I strive to become the person that he believes me to be. v Contributions to presented work The work in this dissertation was done under the direct supervision and guidance of Dr. Judith Hellman. Chapters 1 and 2 contain material previously submitted for publication: S Khakpour, K Wilhelmsen, and J Hellman. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immunity. 2015 Nov;21(8):827-46. K Wilhelmsen, S Khakpour, A Tran, K Sheehan, M Schumacher, F Xu, and J Hellman. The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. Journal of Biological Chemistry. 2014 May 9;289(19):13079- 100. Epub 2014 Mar 18. Chapter 2 data was collected in collaboration with Kevin Wilhelmsen, who performed qPCR, western blot, neutrophil adhesion, and COMT assays, and helped perform in vitro TLR agonist challenge experiments. Alphonso Tran provided assistance with ELISAs. All other experiments were performed by Samira Khakpour Lawton. For data presented in Chapter 3, Fengyun Xu and Alphonso Tran conducted TLR agonist challenge experiments. Erika Wong and Fengyun Xu performed CLP surgeries. Alphonso Tran and Erika Wong helped with the collection and processing of murine plasma samples and assisted with ELISAs. Kevin Wilhelmsen and Arun Prakash helped perform multiplex experiments. All other experiments were performed by Samira Khakpour Lawton. For data presented in Chapter 4, Fengyun Xu performed in vivo TLR vi agonist challenge experiments. The Roth Laboratory at the University of North Carolina Chapel Hill performed the GPCR-ome screening assay. All other experiments were performed by Samira Khakpour Lawton. I would like to acknowledge the following funding sources: UCSF Department of Anesthesia and Perioperative Care, UCSF Biomedical Sciences Graduate Program, NSF Graduate Research Fellowship Program (1144247), and the UCSF REAC Program (Huntington Fund). vii Immune regulation by the endocannabinoid N-arachidonoyl dopamine (NADA) Samira Khakpour Lawton ABSTRACT Arachidonic acid-based lipids, or eicosanoids, are well-known regulators of the inflammatory response. While there are additional classes of eicosanoids that have also been shown to possess immunomodulatory activity, such as the cannabinoids, they remain largely unstudied. We have found that the endocannabinoid N-arachidonoyl dopamine (NADA) decreases inflammatory responses in vitro in endothelial cells after challenge with TLR agonists, and that this activity is dependent upon the cannabinoid receptors (CB1R and CB2R). Furthermore, NADA dramatically reduces systemic inflammation in murine models of bacterial lipopeptide, endotoxemia, and polymicrobial intraabdominal sepsis. Consistent with its classification as a potent endovanilloid, the activity of NADA in vivo depends upon the cation channel transient receptor potential vanilloid 1 (TRPV1) expressed in non-hematopoietic cells and may be mediated through neuronal TRPV1. Furthermore, the activity of NADA systemically, in endothelial cells, and in the hematopoietic compartment is dependent upon CB2R. Finally, we show that the immunomodulatory activity of NADA is mediated in part by its ability to regulate prostanoid production, and its metabolism into the novel lipid prostaglandin D2- dopamine. These data indicate that NADA can modulate inflammatory activation as viii both an endocannabinoid and endovanilloid, and suggests that these pathways may be targeted therapeutically for the treatment of acute inflammatory disorders, such as sepsis. ix TABLE OF CONTENTS Chapter 1: Background .................................................................................................... 1 Chapter 2: The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells ......................................................................................................... 7 Chapter 3: N-arachidonoyl dopamine (NADA) modulates acute systemic inflammation via non-hematopoietic TRPV1 ................................................................................. 80 Chapter 4: N-arachidonoyl dopamine (NADA) affects inflammation by regulating endothelial and systemic prostanoid metabolism .................................................. 126 Chapter 5: Conclusions ................................................................................................ 177 References ................................................................................................................... 182 x LIST OF TABLES Chapter 2 Table 2.1. Mean ΔCt for cannabinoid receptor qPCR data ............................................ 66 Table 2.2. Mean ΔCt for metabolic enzymes qPCR data ............................................... 67 Table 2.3. Cannabinoid receptor agonists/antagonists used in experiments ................. 68 Table 2.4. Mean inflammatory and viability indices, SEM, and significance for cannabinoid receptor agonists/antagonists ............................................................. 69 Chapter 4 Table 4.1. The effects of endocannabinoids on arachidonic acid metabolic enzymes in endothelial cells ..................................................................................................... 165 Table 4.2. Binding affinity of PGD2-DA to GPCRs ........................................................ 167 Table 4.3. List of qPCR primers used .......................................................................... 170 xi LIST OF FIGURES Chapter 1 1.1: Major outputs after endothelial cell TLR pathways are activated .............................. 5 Chapter 2 2.1: ECs express a similar subset of CBR mRNA transcripts ........................................ 31 2.2: ECs express CBR and TRPV1
Recommended publications
  • Chimeric Gpcrs Mimic Distinct Signaling Pathways and Modulate Microglia Responses
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.21.449162; this version posted June 21, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses Rouven Schulz, Medina Korkut-Demirbaş, Gloria Colombo, Sandra Siegert† Author affiliation: Institute of Science and Technology (IST) Austria, Am Campus 1, 3400 Klosterneuburg, Austria † Corresponding author: [email protected] Keywords: G protein coupled receptor (GPCR), DREADD, β2-adrenergic receptor (β2AR/ADRB2), microglia, inflammation, GPR65, GPR109A/HCAR2 Abstract G protein-coupled receptors (GPCRs) regulate multiple processes ranging from cell growth and immune responses to neuronal signal transmission. However, ligands for many GPCRs remain unknown, suffer from off-target effects or have poor bioavailability. Additional challenges exist to dissect cell type-specific responses when the same GPCR is expressed on different cells within the body. Here, we overcome these limitations by engineering DREADD-based GPCR chimeras that selectively bind their agonist clozapine-N-oxide (CNO) and mimic a GPCR-of-interest. We show that the chimeric DREADD-β2-adrenergic receptor (β2AR/ADRB2) triggers comparable responses to levalbuterol on second messenger and kinase activity, post-translational modifications, and protein-protein interactions. Moreover, we successfully recapitulate β2AR-mediated filopodia formation in microglia, a β2AR-expressing immune cell that can drive inflammation in the nervous system. To further dissect microglial inflammation, we compared DREADD-β2AR with two additionally designed DREADD-based chimeras mimicking GPR65 and GPR109A/HCAR2, both enriched in microglia.
    [Show full text]
  • 309 Molecular Role of Dopamine in Anhedonia Linked to Reward
    [Frontiers In Bioscience, Scholar, 10, 309-325, March 1, 2018] Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems Mark S. Gold8, Kenneth Blum,1-7,10 Marcelo Febo1, David Baron,2 Edward J Modestino9, Igor Elman10, Rajendra D. Badgaiyan10 1Department of Psychiatry, McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA, 2Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of South- ern California, Los Angeles, CA, USA, 3Global Integrated Services Unit University of Vermont Center for Clinical and Translational Science, College of Medicine, Burlington, VT, USA, 4Department of Addiction Research, Dominion Diagnostics, LLC, North Kingstown, RI, USA, 5Center for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purbe Medinpur, West Bengal, India, 6Division of Neuroscience Research and Therapy, The Shores Treatment and Recovery Center, Port St. Lucie, Fl., USA, 7Division of Nutrigenomics, Sanus Biotech, Austin TX, USA, 8Department of Psychiatry, Washington University School of Medicine, St. Louis, Mo, USA, 9Depart- ment of Psychology, Curry College, Milton, MA USA,, 10Department of Psychiatry, Wright State University, Boonshoft School of Medicine, Dayton, OH ,USA. TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Anhedonia and food addiction 4. Anhedonia in RDS Behaviors 5. Anhedonia hypothesis and DA as a “Pleasure” molecule 6. Reward genes and anhedonia: potential therapeutic targets 7. Anti-reward system 8. State of At of Anhedonia 9. Conclusion 10. Acknowledgement 11. References 1. ABSTRACT Anhedonia is a condition that leads to the loss like “anti-reward” phenomena. These processes of feelings pleasure in response to natural reinforcers may have additive, synergistic or antagonistic like food, sex, exercise, and social activities.
    [Show full text]
  • Trace Amine-Associated Receptor 1 Activation Regulates Glucose-Dependent
    Trace amine-associated receptor 1 activation regulates glucose-dependent insulin secretion in pancreatic beta cells in vitro by ©Arun Kumar A thesis submitted to the School of Graduate Studies in partial fulfillment of the requirements for the degree of Master of Science Department of Biochemistry, Faculty of Science Memorial University of Newfoundland FEBRUARY 2021 St. John’s, Newfoundland and Labrador i Abstract Trace amines are a group of endogenous monoamines which exert their action through a family of G protein-coupled receptors known as trace amine-associated receptors (TAARs). TAAR1 has been reported to regulate insulin secretion from pancreatic beta cells in vitro and in vivo. This study investigates the mechanism(s) by which TAAR1 regulates insulin secretion. The insulin secreting rat INS-1E -cell line was used for the study. Cells were pre-starved (30 minutes) and then incubated with varying concentrations of glucose (2.5 – 20 mM) or KCl (3.6 – 60 mM) for 2 hours in the absence or presence of various concentrations of the selective TAAR1 agonist RO5256390. Secreted insulin per well was quantified using ELISA and normalized to the total protein content of individual cultures. RO5256390 significantly (P < 0.0001) increased glucose- stimulated insulin secretion in a dose-dependent manner, with no effect on KCl-stimulated insulin secretion. Affymetrix-microarray data analysis identified genes (Gnas, Gng7, Gngt1, Gria2, Cacna1e, Kcnj8, and Kcnj11) whose expression was associated with changes in TAAR1 in response to changes in insulin secretion in pancreatic beta cell function. The identified potential links to TAAR1 supports the regulation of glucose-stimulated insulin secretion through KATP ion channels.
    [Show full text]
  • Genome-Wide Prediction of Small Molecule Binding to Remote
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.236729; this version posted August 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Genome-wide Prediction of Small Molecule Binding 2 to Remote Orphan Proteins Using Distilled Sequence 3 Alignment Embedding 1 2 3 4 4 Tian Cai , Hansaim Lim , Kyra Alyssa Abbu , Yue Qiu , 5,6 1,2,3,4,7,* 5 Ruth Nussinov , and Lei Xie 1 6 Ph.D. Program in Computer Science, The Graduate Center, The City University of New York, New York, 10016, USA 2 7 Ph.D. Program in Biochemistry, The Graduate Center, The City University of New York, New York, 10016, USA 3 8 Department of Computer Science, Hunter College, The City University of New York, New York, 10065, USA 4 9 Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, 10016, USA 5 10 Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, 11 Frederick, MD 21702, USA 6 12 Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel 13 Aviv, Israel 7 14 Helen and Robert Appel Alzheimer’s Disease Research Institute, Feil Family Brain & Mind Research Institute, Weill 15 Cornell Medicine, Cornell University, New York, 10021, USA * 16 [email protected] 17 July 27, 2020 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.236729; this version posted August 5, 2020.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • Pharmacogenomic Characterization in Bipolar Spectrum Disorders
    pharmaceutics Review Pharmacogenomic Characterization in Bipolar Spectrum Disorders Stefano Fortinguerra 1,2 , Vincenzo Sorrenti 1,2,3 , Pietro Giusti 2, Morena Zusso 2 and Alessandro Buriani 1,2,* 1 Maria Paola Belloni Center for Personalized Medicine, Data Medica Group (Synlab Limited), 35131 Padova, Italy; [email protected] (S.F.); [email protected] (V.S.) 2 Department of Pharmaceutical & Pharmacological Sciences, University of Padova, 35131 Padova, Italy; [email protected] (P.G.); [email protected] (M.Z.) 3 Bendessere™ Study Center, Solgar Italia Multinutrient S.p.A., 35131 Padova, Italy * Correspondence: [email protected] Received: 25 November 2019; Accepted: 19 December 2019; Published: 21 December 2019 Abstract: The holistic approach of personalized medicine, merging clinical and molecular characteristics to tailor the diagnostic and therapeutic path to each individual, is steadily spreading in clinical practice. Psychiatric disorders represent one of the most difficult diagnostic challenges, given their frequent mixed nature and intrinsic variability, as in bipolar disorders and depression. Patients misdiagnosed as depressed are often initially prescribed serotonergic antidepressants, a treatment that can exacerbate a previously unrecognized bipolar condition. Thanks to the use of the patient’s genomic profile, it is possible to recognize such risk and at the same time characterize specific genetic assets specifically associated with bipolar spectrum disorder, as well as with the individual response to the various therapeutic options. This provides the basis for molecular diagnosis and the definition of pharmacogenomic profiles, thus guiding therapeutic choices and allowing a safer and more effective use of psychotropic drugs. Here, we report the pharmacogenomics state of the art in bipolar disorders and suggest an algorithm for therapeutic regimen choice.
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • Identification of Biomarkers for Sarcoidosis and Tuberculosis of The
    DATABASE ANALYSIS e-ISSN 1643-3750 © Med Sci Monit, 2020; 26: e925438 DOI: 10.12659/MSM.925438 Received: 2020.04.26 Accepted: 2020.05.11 Identification of Biomarkers for Sarcoidosis and Available online: 2020.05.28 Published: 2020.07.23 Tuberculosis of the Lung Using Systematic and Integrated Analysis Authors’ Contribution: ABCEF 1 Min Zhao 1 Department of Respiratory and Critical Care Medicine, The Second Hospital of Study Design A BCE 1 Xin Di Jilin University, Changchun, Jilin, P.R. China Data Collection B 2 Department of Oncology and Hematology, The Second Hospital of Jilin University, Statistical Analysis C CDE 2 Xin Jin Changchun, Jilin, P.R. China Data Interpretation D BF 1 Chang Tian Manuscript Preparation E CF 1 Shan Cong Literature Search F Funds Collection G BF 1 Jiangyin Liu ABDEG 1 Ke Wang Corresponding Author: Ke Wang, e-mail: [email protected] Source of support: This study was supported by the Technology Research Funds of Jilin Province (20190303162SF), the Natural Science Foundation of Jilin Province (20180101103JC), and the Medical and Health Project Funds of Jilin Province (20191102012YY) Background: Sarcoidosis (SARC) is a multisystem inflammatory disease of unknown etiology and pulmonary tuberculosis (PTB) is caused by Mycobacterium tuberculosis. Both of these diseases affect lungs and lymph nodes and share similar clinical manifestations. However, the underlying mechanisms for the similarities and differences in ge- netic characteristics of SARC and PTB remain unclear. Material/Methods: Three datasets (GSE16538, GSE20050, and GSE19314) were retrieved from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) in SARC and PTB were identified using GEO2R online analyz- er and Venn diagram software.
    [Show full text]
  • Integrative Analysis of Mirna–Mrna Network in High Altitude Retinopathy by Bioinformatics Analysis
    Bioscience Reports (2021) 41 BSR20200776 https://doi.org/10.1042/BSR20200776 Research Article Integrative analysis of miRNA–mRNA network in high altitude retinopathy by bioinformatics analysis Tong Su1,2,*, Chufeng Gu1,2,*,DejiDraga3,*, Chuandi Zhou1,2, Thashi Lhamo3, Zhi Zheng1,2 and Qinghua Qiu1,2,3 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China; 2National Clinical Research Center for Eye Downloaded from http://portlandpress.com/bioscirep/article-pdf/41/1/BSR20200776/902020/bsr-2020-0776.pdf by guest on 26 September 2021 Diseases; Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai Engineering Center for Visual Science and Photomedicine; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, P.R. China; 3Department of Ophthalmology, Shigatse People’s Hospital, Shigatse, Xizang, P.R. China Correspondence: Qinghua Qiu ([email protected]) or Zhi Zheng ([email protected]) High-altitude retinopathy (HAR) is an ocular manifestation of acute oxygen deficiency at high altitudes. Although the pathophysiology of HAR has been revealed by many studies in recent years, the molecular mechanism is not yet clear. Our study aimed to systemati- cally identify the genes and microRNA (miRNA) and explore the potential biomarkers asso- ciated with HAR by integrated bioinformatics analysis. The mRNA and miRNA expression profiles were obtained from the Gene Expression Omnibus database. We performed Gene Ontology functional annotations and Kyoto Encyclopedia of Genes and Genomes path- way analysis. Potential target gene analysis and miRNA–mRNA network analysis were also conducted. Quantitative RT-PCR (qRT-PCR) was used to validate the results of the bioinfor- matics analysis.
    [Show full text]
  • G Protein-Coupled Receptors in Stem Cell Maintenance and Somatic Reprogramming to Pluripotent Or Cancer Stem Cells
    BMB Reports - Manuscript Submission Manuscript Draft Manuscript Number: BMB-14-250 Title: G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells Article Type: Mini Review Keywords: G protein-coupled receptors; stem cell maintenance; somatic reprogramming; cancer stem cells; pluripotent stem cell Corresponding Author: Ssang-Goo Cho Authors: Ssang-Goo Cho1,*, Hye Yeon Choi1, Subbroto Kumar Saha1, Kyeongseok Kim1, Sangsu Kim1, Gwang-Mo Yang1, BongWoo Kim1, Jin-hoi Kim1 Institution: 1Department of Animal Biotechnology, Animal Resources Research Center, and Incurable Disease Animal Model and Stem Cell Institute (IDASI), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea, UNCORRECTED PROOF 1 G protein-coupled receptors in stem cell maintenance and somatic reprogramming to 2 pluripotent or cancer stem cells 3 4 Hye Yeon Choi, Subbroto Kumar Saha, Kyeongseok Kim, Sangsu Kim, Gwang-Mo 5 Yang, BongWoo Kim, Jin-hoi Kim, and Ssang-Goo Cho 6 7 Department of Animal Biotechnology, Animal Resources Research Center, and 8 Incurable Disease Animal Model and Stem Cell Institute (IDASI), Konkuk University, 9 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea 10 * 11 Address correspondence to Ssang-Goo Cho, Department of Animal Biotechnology and 12 Animal Resources Research Center. Konkuk University, 120 Neungdong-ro, Gwangjin- 13 gu, Seoul 143-701, Republic of Korea. Tel: 82-2-450-4207, Fax: 82-2-450-1044, E-mail: 14 [email protected] 15 16 17 18 19 1 UNCORRECTED PROOF 20 Abstract 21 The G protein-coupled receptors (GPCRs) compose the third largest gene family in the 22 human genome, representing more than 800 distinct genes and 3–5% of the human genome.
    [Show full text]
  • The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
    International Journal of Molecular Sciences Review The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature Jan Korbecki 1 , Klaudyna Kojder 2, Patrycja Kapczuk 1, Patrycja Kupnicka 1 , Barbara Gawro ´nska-Szklarz 3 , Izabela Gutowska 4 , Dariusz Chlubek 1 and Irena Baranowska-Bosiacka 1,* 1 Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] (J.K.); [email protected] (P.K.); [email protected] (P.K.); [email protected] (D.C.) 2 Department of Anaesthesiology and Intensive Care, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-281 Szczecin, Poland; [email protected] 3 Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] 4 Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wlkp. 72 Av., 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-914661515 Abstract: Hypoxia is an integral component of the tumor microenvironment. Either as chronic or cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible factor-1 (HIF-1) and nuclear factor (NF-κB), with cycling hypoxia showing a stronger proinflammatory influ- ence. One of the systems affected by hypoxia is the CXC chemokine system. This paper reviews all available information on hypoxia-induced changes in the expression of all CXC chemokines (CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, CXCL12 Citation: Korbecki, J.; Kojder, K.; Kapczuk, P.; Kupnicka, P.; (SDF-1), CXCL13, CXCL14, CXCL15, CXCL16, CXCL17) as well as CXC chemokine receptors— Gawro´nska-Szklarz,B.; Gutowska, I.; CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CXCR7 and CXCR8.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]